Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report.
Smith
D H
DH
Praxis Biologics, Inc., Rochester, New York.
Madore
D V
DV
Eby
R J
RJ
Anderson
P W
PW
Insel
R A
RA
Johnson
C L
CL
D000375:Aging / Q000276:immunology; D016667:Bacterial Capsules; D001426:Bacterial Proteins / Q000009:adverse effects / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology*; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000276:immunology; D004347:Drug Interactions; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D011135:Polysaccharides, Bacterial; D013997:Time Factors
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D011135:Polysaccharides, Bacterial; C061963:HibTITER protein, Haemophilus influenzae